BioPharma Dive May 10, 2021
Sponsored content By Koneksa Health

Given the increased use of wearable devices, such as smart watches, which are able to monitor a broad range of physiological activities, it makes sense that actigraphy is a growing trend in clinical trials. Actigraphy is a non-invasive way to monitor human rest and activity. Some use cases in clinical trials are more obvious, such as in the study of Parkinson’s disease, where a wearable sensor can measure tremors in order to track the ON and OFF activity cycles indicative of levodopa treatment. But the uses of actigraphy are much wider, including everything from behavioral, to CNS, to respiratory, circulatory and oncology-related conditions.

Broadly, actigraphy can be used to evaluate step counts, total sleep time per sleep period, activity intensity...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Digital Health, Patient / Consumer, Pharma, Pharma / Biotech, Technology, Wearables
Low-cost wearable sensors may lead to better Parkinson’s care
Fitness trackers and phones can help monitor multiple sclerosis
Digital Phenotyping: emerging HealthTech sub sector is 'one to watch in 2024 and 2025'
Apple Watch’s ‘Foggy’ gets FDA medical device listing for Parkinson’s
At-Home Patients and AI: Q&A with Riccardo Butta

Share This Article